©istock.com/Andrea Obzerova
Interdisciplinary CompetenceMolecular Diagnostics
Know how in the analysis of genetic material.
For the benefit of patients.

IllnessProstate cancer, germline mutations [uroweb guidelines]

Request form illness

Summary

Short information

Comprehensive panel for mutation detection in Prostate cancer comprising 12 guideline-curated and altogether 33 curated genes

ID
PP0100
Number of genes
12 Accredited laboratory test
Examined sequence length
43,7 kb (Core-/Core-canditate-Genes)
- (Extended panel: incl. additional genes)
Analysis Duration
on request
Material
  • EDTA-anticoagulated blood (3-5 ml)
Diagnostic indications

NGS + SNP

[Sanger]

 

Gene panel

Selected genes

NameExon Length (bp)OMIM-GReferenz-Seq.Heredity
ATM9171NM_000051.4AD
BRCA15592NM_007294.4AD
BRCA210257NM_000059.4AD
CHEK21632NM_007194.4AD
EPCAM945NM_002354.3Sus
HOXB13855NM_006361.6n.k.
MLH12271NM_000249.4AR
MSH22805NM_000251.3AD, AR
MSH64083NM_000179.3AD, AR
NBN2265NM_002485.5AR
PMS22589NM_000535.7AD
TP531182NM_000546.6AD

Informations about the disease

Clinical Comment

Early onset, either asymptomatic or causes mictionary symptoms, erectile dysfunction, bone pain, venous compression, infectious/inflammatory syndrome by metastases; familial antecedents

 

Synonyms
  • Alias: Prostata-Karzinom, familiäres
  • Alias: Prostate cancer, familial
  • Allelic: Barrett esophagus/esophageal adenocarcinoma (MSR1)
  • Allelic: Breast cancer, early-onset, susceptibility to (BRIP1)
  • Allelic: Breast cancer, lobular (CDH1)
  • Allelic: Breast cancer, susceptibility to (ATM)
  • Allelic: Breast cancer, susceptibility to (CHEK2)
  • Allelic: Breast cancer, susceptibility to (PALB2)
  • Allelic: Breast-ovarian cancer, familial, 1 (BRCA1)
  • Allelic: Breast-ovarian cancer, familial, 2 (BRCA2)
  • Allelic: Breast-ovarian cancer, familial, susceptibility to, 4 (RAD51D)
  • Allelic: Colorectal cancer, susceptibility to (CHEK2)
  • Allelic: Li-Fraumeni syndrome 2 (CHEK2)
  • Allelic: Multiple endocrine neoplasia, type IV (CDKN1B)
  • Allelic: Nabais Sa-de Vries syndrome, type 1 + 2 (SPOP)
  • Allelic: Nijmegen breakage syndrome (NBN)
  • Allelic: Renal cell carcinoma (HNF1B)
  • Allelic: Vitamin D-dependent rickets, type 3 (CYP3A4)
  • Allelic: Wilms tumor (BRCA2)
  • "Prostate cancer antimetastasis gene KAI1" (CD82)
  • Ataxia-telangiectasia (ATM)
  • Fanconi anemia, complementation group A (FANCA)
  • Fanconi anemia, complementation group D1 (BRCA2)
  • Fanconi anemia, complementation group J (BRIP1)
  • Fanconi anemia, complementation group N (PALB2)
  • Fanconi anemia, complementation group S (BRCA1)
  • Mismatch repair cancer syndrome 1, 2, 3, 4 (MLH1, MSH2, MSH6, PMS2)
  • Prostate cancer (BRCA2)
  • Prostate cancer 1 (RNASEL)
  • Prostate cancer, familial, susceptibility to (CHEK2)
  • Prostate cancer, hereditary, 1 (RNASEL)
  • Prostate cancer, hereditary, 12 (EHBP1)
  • Prostate cancer, hereditary, 13 (MSMB)
  • Prostate cancer, hereditary, 2, susceptibility to (ELAC2)
  • Prostate cancer, hereditary, 9 (HOXB13)
  • Prostate cancer, somatic (KLF6)
  • Prostate cancer, somatic (MAD1L1)
  • Prostate cancer, somatic (MXI1)
  • Prostate cancer, somatic (PTEN)
  • Prostate cancer, susceptibility to (CDH1)
  • Prostate cancer/brain cancer, susceptibility to (EPHB2)
Heredity, heredity patterns etc.
  • AD
  • AR
  • Sus
  • n.k.
OMIM-Ps
  • Multiple OMIM-Ps
ICD10 Code

Bioinformatics and clinical interpretation

No text defined